Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
about
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@en
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@nl
type
label
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@en
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@nl
prefLabel
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@en
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@nl
P2093
P1476
Subcutaneous terbutaline use in CKD to reduce potassium concentrations.
@en
P2093
Donald Cronin
Kevin M Sowinski
Michael A Kraus
P304
P356
10.1053/J.AJKD.2005.02.016
P577
2005-06-01T00:00:00Z